Investor Relations.

Trendlines invests in, and incubates innovation-based medtech and agrifood technologies.

As intensely hands-on investors, we are involved in all aspects of our portfolio companies from technology development to business building.

Stock Information
For Corporate Governance please press the form Reset button.
21 Feb, 2024 Cessation of Todd Dollinger as co-Chair
21 Feb, 2024 Cessation of Steve Rhodes as co-Chair
21 Feb, 2024 Changes to the Composition of the Board and its Committees
21 Feb, 2024 Trendlines Reports FY 2023 Unaudited Results
13 Feb, 2024 Cessation of Kobby Greenberg as Trendlines Innovation Labs CEO
05 Feb, 2024 Update on LOI Regarding Acquisiton of Portfolio Company
01 Feb, 2024 January 2024 Monthly Update
12 Jan, 2024 SGM December 2023 Minutes
08 Jan, 2024 Changes in Percentage Level of Substantial Shareholder - Bank of New York Mellon
04 Jan, 2024 December 2023 Monthly Update
03 Jan, 2024 Profit Warning Announcement
Shira Zimmerman
Investor Communications
The Trendlines Group
investors@trendlines.com
Skip to content